AU2003228193B2 - Method for albumin purification - Google Patents

Method for albumin purification Download PDF

Info

Publication number
AU2003228193B2
AU2003228193B2 AU2003228193A AU2003228193A AU2003228193B2 AU 2003228193 B2 AU2003228193 B2 AU 2003228193B2 AU 2003228193 A AU2003228193 A AU 2003228193A AU 2003228193 A AU2003228193 A AU 2003228193A AU 2003228193 B2 AU2003228193 B2 AU 2003228193B2
Authority
AU
Australia
Prior art keywords
matrix
rhsa
ccs
cation exchange
cation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2003228193A
Other languages
English (en)
Other versions
AU2003228193A1 (en
Inventor
Makonnen Belew
Mei Yan Li
Wei Zhang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NORTH CHINA PHARMACEUTICAL GROUP Corp
Global Life Sciences Solutions USA LLC
Original Assignee
NORTH CHINA PHARMACEUTICAL GROUP CORP
GE Healthcare Bio Sciences Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by NORTH CHINA PHARMACEUTICAL GROUP CORP, GE Healthcare Bio Sciences Corp filed Critical NORTH CHINA PHARMACEUTICAL GROUP CORP
Publication of AU2003228193A1 publication Critical patent/AU2003228193A1/en
Assigned to GE HEALTHCARE BIO-SCIENCES AB, NORTH CHINA PHARMACEUTICAL GROUP CORPORATION reassignment GE HEALTHCARE BIO-SCIENCES AB Request for Assignment Assignors: AMERSHAM BIOSCIENCES AB, NORTH CHINA PHARMACEUTICAL GROUP CORPORATION
Application granted granted Critical
Publication of AU2003228193B2 publication Critical patent/AU2003228193B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/76—Albumins
    • C07K14/765—Serum albumin, e.g. HSA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AU2003228193A 2002-05-15 2003-05-09 Method for albumin purification Ceased AU2003228193B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE0201518A SE526227C2 (sv) 2002-05-15 2002-05-15 Metod för rening av rekombinant humant serumalbumin
SE0201518-8 2002-05-15
PCT/SE2003/000766 WO2003097692A1 (en) 2002-05-15 2003-05-09 Method for albumin purification

Publications (2)

Publication Number Publication Date
AU2003228193A1 AU2003228193A1 (en) 2003-12-02
AU2003228193B2 true AU2003228193B2 (en) 2009-05-07

Family

ID=20287916

Family Applications (2)

Application Number Title Priority Date Filing Date
AU2003228193A Ceased AU2003228193B2 (en) 2002-05-15 2003-05-09 Method for albumin purification
AU2003232704A Abandoned AU2003232704A1 (en) 2002-05-15 2003-05-15 Method, use and kit for separating albumin from contaminants in a liquid

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU2003232704A Abandoned AU2003232704A1 (en) 2002-05-15 2003-05-15 Method, use and kit for separating albumin from contaminants in a liquid

Country Status (13)

Country Link
US (2) US7423124B2 (enExample)
EP (2) EP1504031B1 (enExample)
JP (2) JP2006502098A (enExample)
CN (1) CN100463921C (enExample)
AT (1) ATE335006T1 (enExample)
AU (2) AU2003228193B2 (enExample)
BR (2) BRPI0309992B8 (enExample)
CA (2) CA2483612A1 (enExample)
DE (1) DE60307262T2 (enExample)
ES (1) ES2268362T3 (enExample)
IL (1) IL164844A (enExample)
SE (1) SE526227C2 (enExample)
WO (2) WO2003097692A1 (enExample)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8802146B2 (en) * 1998-11-06 2014-08-12 Neomend, Inc. Systems, methods, and compositions for prevention of tissue adhesion
PT1599463E (pt) * 2003-01-28 2013-09-03 Du Pont Insecticidas à base de ciano-antranilamida
EP1608457A1 (en) * 2003-03-12 2005-12-28 Fresenius Kabi Deutschland GmbH Use of recombinant albumin in dialysis after liver failure
AU2005235634B2 (en) * 2004-04-23 2011-10-20 Conjuchem Biotechnologies Inc. Method for the purification of albumin conjugates
CN1854155B (zh) * 2005-04-29 2010-11-17 华北制药集团新药研究开发有限责任公司 一种纯化rHSA的方法
AR067537A1 (es) * 2007-07-17 2009-10-14 Hoffmann La Roche Purificacion de polipeptidos pegilados
AR067536A1 (es) 2007-07-17 2009-10-14 Hoffmann La Roche Metodo para obtener una eritropoyetina mono-pegilada en una forma sustancialmente homogenea
CN101978268B (zh) * 2008-03-31 2014-04-23 积水医疗株式会社 纯化血清白蛋白及免疫学测定方法
US8753868B2 (en) 2008-08-04 2014-06-17 General Electric Company Method and system for selective isolation of target biological molecules in a general purpose system
CN101768206B (zh) * 2008-12-31 2013-05-15 华北制药集团新药研究开发有限责任公司 一种重组人血清白蛋白的纯化方法及其应用
CN102369276B (zh) 2009-02-20 2015-02-04 文特里亚生物科学公司 含有蛋白质组合的细胞培养基
SG10201710439UA (en) * 2010-05-25 2018-01-30 Genentech Inc Methods of purifying polypeptides
CN102127164B (zh) 2010-12-20 2013-01-30 武汉禾元生物科技有限公司 一种从水稻种子中提取重组人血清白蛋白的方法
CN102532254B (zh) * 2010-12-24 2015-06-24 武汉禾元生物科技股份有限公司 一种从水稻种子中分离纯化重组人血清白蛋白的方法
WO2013134251A2 (en) * 2012-03-08 2013-09-12 Bio-Rad Laboratories, Inc. Anionic exchange-hydrophobic mixed mode
CN103880947B (zh) 2012-12-21 2016-01-13 武汉禾元生物科技股份有限公司 一种分离纯化高纯度重组人血清白蛋白的层析方法
CN103923211A (zh) * 2014-05-08 2014-07-16 齐智 一种医药级重组人血清白蛋白的纯化方法
JP2018517415A (ja) 2015-06-10 2018-07-05 ナントクエスト インコーポレイテッド がんを処置するための改変ｎｋ−９２細胞
CN106117347A (zh) * 2015-12-09 2016-11-16 烟台大学 一种疏水层析制备高纯度藻红蛋白的方法
CN106117326A (zh) * 2015-12-09 2016-11-16 烟台大学 一种离心法结合阴离子交换层析介质制备藻红蛋白的方法
CN106146631A (zh) * 2015-12-09 2016-11-23 烟台大学 一种离心技术结合疏水层析介质制备藻红蛋白的方法
KR20220066393A (ko) 2019-09-24 2022-05-24 리제너론 파아마슈티컬스, 인크. 크로마토그래피의 사용 및 재생을 위한 시스템 및 방법
US11739166B2 (en) 2020-07-02 2023-08-29 Davol Inc. Reactive polysaccharide-based hemostatic agent
US12161777B2 (en) 2020-07-02 2024-12-10 Davol Inc. Flowable hemostatic suspension
US20230331772A1 (en) 2020-12-08 2023-10-19 Tonghua Anrate Biopharmaceutical Co., Ltd Method for purification of recombinant proteins
CN116744984A (zh) 2020-12-28 2023-09-12 达沃有限公司 包含蛋白质和多官能化改性的基于聚乙二醇的交联剂的反应性干粉状止血材料
CN113461804A (zh) * 2021-08-09 2021-10-01 山东健通生物科技有限公司 减少重组人血白蛋白发酵过程中色素的方法
CN113880908B (zh) * 2021-08-25 2024-05-14 北京伟德杰生物科技有限公司 纯化重组人血清白蛋白的融合蛋白的方法
CN113735962B (zh) * 2021-08-27 2023-11-10 常熟纳微生物科技有限公司 一种从猪血中纯化重组人血清白蛋白的方法及应用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4093612A (en) 1975-08-04 1978-06-06 Research Corporation Selective removal of albumin from blood fluids and compositions therefore
FR2403098A1 (fr) 1977-09-19 1979-04-13 Merieux Inst Nouveau materiau capable de fixer de facon reversible des macromolecules biologiques, sa preparation et son application
US5849874A (en) * 1991-07-12 1998-12-15 Gist-Brocades, N.V. Process for the purification of serum albumin
IE20000781A1 (en) * 1991-07-12 2001-02-21 Dsm Nv Process for the purification of serum albumin
US5440018A (en) * 1992-05-20 1995-08-08 The Green Cross Corporation Recombinant human serum albumin, process for producing the same and pharmaceutical preparation containing the same
US5521287A (en) * 1992-05-20 1996-05-28 The Green Cross Corporation Recombinant human serum albumin, process for producing the same and pharmaceutical preparation containing the same
JPH07102148B2 (ja) * 1992-05-20 1995-11-08 株式会社ミドリ十字 遺伝子操作により得られるヒト血清アルブミンの製造方法、およびそれにより得られるヒト血清アルブミン含有組成物
CA2116385A1 (en) * 1993-02-25 1994-08-26 Akinori Sumi Human serum albumin and process for producing the same
DK0658569T3 (da) 1993-12-17 2005-02-07 Mitsubishi Pharma Corp Fremgangsmåde til affarvning af humant serumalbumin
DK0699687T3 (da) 1994-08-31 2004-04-26 Mitsubishi Pharma Corp Fremgangsmåde til oprensning af rekombinant humant serumalbumin
JP3840674B2 (ja) * 1994-08-31 2006-11-01 三菱ウェルファーマ株式会社 遺伝子操作に由来するヒト血清アルブミンの精製方法
GB9902000D0 (en) * 1999-01-30 1999-03-17 Delta Biotechnology Ltd Process
SE0002688D0 (sv) * 2000-07-17 2000-07-17 Amersham Pharm Biotech Ab Adsorption method and ligands
JP4798832B2 (ja) * 2000-10-24 2011-10-19 一般財団法人化学及血清療法研究所 ヒト血清アルブミン多量体の除去方法

Also Published As

Publication number Publication date
US20050214902A1 (en) 2005-09-29
JP2006512283A (ja) 2006-04-13
CA2483616A1 (en) 2003-11-27
CN100463921C (zh) 2009-02-25
US7351801B2 (en) 2008-04-01
SE0201518D0 (sv) 2002-05-15
WO2003097692A1 (en) 2003-11-27
IL164844A (en) 2009-09-01
IL164844A0 (en) 2005-12-18
JP2006502098A (ja) 2006-01-19
ATE335006T1 (de) 2006-08-15
EP1504031A1 (en) 2005-02-09
AU2003232704A1 (en) 2003-12-02
BRPI0309992B1 (pt) 2020-12-22
EP1504032A1 (en) 2005-02-09
EP1504031B1 (en) 2006-08-02
CA2483612A1 (en) 2003-11-27
WO2003097693A1 (en) 2003-11-27
JP4559216B2 (ja) 2010-10-06
CN1496993A (zh) 2004-05-19
BRPI0309992B8 (pt) 2023-03-21
US20050215765A1 (en) 2005-09-29
SE526227C2 (sv) 2005-08-02
ES2268362T3 (es) 2007-03-16
AU2003228193A1 (en) 2003-12-02
US7423124B2 (en) 2008-09-09
BR0309992A (pt) 2005-03-01
DE60307262D1 (de) 2006-09-14
DE60307262T2 (de) 2007-06-28

Similar Documents

Publication Publication Date Title
AU2003228193B2 (en) Method for albumin purification
RU2007132851A (ru) Способ мягкой распределительной хроматографии
McCreath et al. Expanded bed affinity chromatography of dehydrogenases from bakers' yeast using dye–ligand perfluoropolymer supports
JP3768485B2 (ja) 血清アルブミンの精製方法
US6908749B2 (en) Method for preparing human serum albumin containing heat-treatment
JP2004535197A (ja) 酵素の精製方法およびその方法で製造された精製済み酵素並びに該酵素の用途
CA2395589C (en) Method for removing multimers of human serum albumin
JP2024543701A (ja) 突然変異を起こしたプロテインａのｃドメイン及びその適用
EP1681299B1 (en) Methods for purifying highly anionic proteins
Wakefield et al. Isolation of a membrane protein by chromatofocusing: cytochrome b-561 of the adrenal chromaffin granule
JPH08116985A (ja) 遺伝子操作に由来するヒト血清アルブミンの精製方法
WO1999010370A1 (en) A simple, environmentally benign, method for purifying protein a
KR20240135666A (ko) 단백질 a의 b 도메인과 z 도메인 돌연변이체, 및 이의 응용
KR20050016877A (ko) 알부민 정제 방법
CN110770251A (zh) 纯化白蛋白融合蛋白的方法
HUT71326A (en) Purification of kringle containing proteins, and especially t-pa
IE910410A1 (en) A process for purifying lipocortins
NARAYANAN Application of liquid Chromatography to the Purification of Proteins and Peptides
JPS597694B2 (ja) 不活化トロンビンゲルによるアンチトロンビン３の精製法
Lowe Graham zyxwvutsrqponmlkj
JP2007130025A (ja) 遺伝子操作に由来するヒト血清アルブミンの精製方法

Legal Events

Date Code Title Description
TC Change of applicant's name (sec. 104)

Owner name: NORTH CHINA PHARMACEUTICAL GROUP CORPORATION; GE H

Free format text: FORMER NAME: AMERSHAM BIOSCIENCES AB; NORTH CHINA PHARMACEUTICAL GROUP CORPORATION

FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired